Mizuho Markets Americas LLC Has $75.89 Million Stake in Cencora, Inc. $COR

Mizuho Markets Americas LLC lifted its position in shares of Cencora, Inc. (NYSE:COR) by 5.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 224,700 shares of the company’s stock after buying an additional 11,900 shares during the quarter. Cencora comprises about 1.5% of Mizuho Markets Americas LLC’s holdings, making the stock its 16th largest position. Mizuho Markets Americas LLC owned 0.12% of Cencora worth $75,892,000 at the end of the most recent reporting period.

Other hedge funds have also bought and sold shares of the company. Oakworth Capital Inc. bought a new stake in Cencora during the fourth quarter valued at $26,000. Elyxium Wealth LLC bought a new position in shares of Cencora in the 4th quarter worth about $27,000. Archer Investment Corp raised its position in shares of Cencora by 134.3% in the 4th quarter. Archer Investment Corp now owns 82 shares of the company’s stock worth $28,000 after acquiring an additional 47 shares in the last quarter. IAG Wealth Partners LLC acquired a new position in shares of Cencora in the 3rd quarter valued at about $30,000. Finally, Cloud Capital Management LLC acquired a new position in shares of Cencora in the 3rd quarter valued at about $31,000. Institutional investors own 97.52% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts recently commented on COR shares. Robert W. Baird decreased their target price on Cencora from $420.00 to $339.00 and set an “outperform” rating for the company in a research note on Thursday, May 7th. Barclays lifted their price target on shares of Cencora from $400.00 to $425.00 and gave the company an “overweight” rating in a research note on Friday, February 13th. Weiss Ratings reaffirmed a “buy (b)” rating on shares of Cencora in a research note on Monday, May 4th. Morgan Stanley set a $342.00 price objective on shares of Cencora in a report on Friday, May 8th. Finally, JPMorgan Chase & Co. upped their target price on shares of Cencora from $417.00 to $419.00 and gave the stock an “overweight” rating in a report on Tuesday, February 10th. Twelve investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $380.25.

Cencora Stock Up 3.6%

COR opened at $275.01 on Friday. Cencora, Inc. has a twelve month low of $244.82 and a twelve month high of $377.54. The company’s 50-day moving average price is $305.70 and its two-hundred day moving average price is $336.77. The stock has a market cap of $53.51 billion, a price-to-earnings ratio of 21.09, a PEG ratio of 1.22 and a beta of 0.64. The company has a quick ratio of 0.59, a current ratio of 0.95 and a debt-to-equity ratio of 3.40.

Cencora (NYSE:COR) last issued its quarterly earnings results on Wednesday, May 6th. The company reported $4.75 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.82 by ($0.07). Cencora had a return on equity of 135.20% and a net margin of 0.78%.The company had revenue of $78.36 billion for the quarter, compared to analysts’ expectations of $81.09 billion. During the same quarter in the previous year, the business earned $4.42 EPS. The company’s revenue for the quarter was up 3.9% on a year-over-year basis. Cencora has set its FY 2026 guidance at 17.650-17.900 EPS. As a group, equities analysts expect that Cencora, Inc. will post 17.76 earnings per share for the current year.

Cencora Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Monday, June 1st. Shareholders of record on Friday, May 15th will be given a dividend of $0.60 per share. This represents a $2.40 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date is Friday, May 15th. Cencora’s dividend payout ratio (DPR) is currently 18.40%.

Cencora declared that its board has approved a share buyback program on Thursday, May 21st that authorizes the company to repurchase $2.00 billion in shares. This repurchase authorization authorizes the company to repurchase up to 3.9% of its shares through open market purchases. Shares repurchase programs are usually a sign that the company’s board of directors believes its shares are undervalued.

Cencora Profile

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.